← Leaderboards
Juan P Brito Campana
Mayo Clinic Rochester
$3,769,661
Attributed
$5,342,244
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2022–25$2.5M$1.9M$1.3M$625K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$5,342,244 · 3
By mechanism
R01$3,145,166 · 2
R37$2,197,078 · 1
Top collaborators
- Rozalina Grubina Mccoy4 shared
- Naykky Singh Ospina1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Alfonso Eirin$3,910,400
- Martin Ernesto Fernandez-Zapico$10,185,222
- Rozalina Grubina McCoy$3,562,219
- Dennis M Black$9,656,727
- Asghar Rezaei$737,209
Others in their field
Other Rising Stars on “Sampling”
- Katherine M Thibault · Battelle Memorial Institute$134,148,552
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Bridget Murphy · Broad Institute, Inc.$23,600,775
- Jinsy Andrews · Columbia University Health Sciences$21,294,649
- Sabrina Paganoni · Massachusetts General Hospital$20,824,388
- Suma Babu · Massachusetts General Hospital$20,824,388
Research focus
SamplingRecommendationEvaluationHealth SystemMortalityMultidisciplinaryData SetPatient CareCaringPersonsHigh RiskEndocrinologyPreventCostMedicalPatient OrientedHealth PlanAdultGuidelinesFutureHealth Care DeliveryEnsureDiagnosisData Warehouse
Grant awards (9)
Comparative Effectiveness and Safety of Osteoporosis Drug Therapies$810,627
R01 · FY2025 · AG · contact PI
Understanding and addressing the lack of and delayed screening for primary Aldosteronism$726,611
R01 · FY2025 · HL · contact PI
De-implementation of inappropriate thyroid ultrasound$556,224
R37 · FY2025 · CA · contact PI
De-implementation of inappropriate thyroid ultrasound$630,402
R37 · FY2024 · CA · contact PI
Comparative Effectiveness and Safety of Osteoporosis Drug Therapies$545,907
R01 · FY2024 · AG · contact PI
De-implementation of inappropriate thyroid ultrasound$541,889
R37 · FY2023 · CA · contact PI
Comparative Effectiveness and Safety of Osteoporosis Drug Therapies$530,459
R01 · FY2023 · AG · contact PI
Comparative Effectiveness and Safety of Osteoporosis Drug Therapies$531,562
R01 · FY2022 · AG · contact PI
De-implementation of inappropriate thyroid ultrasound$468,563
R37 · FY2022 · CA · contact PI